CMG제약
058820KOSDAQ의약품 제조업46.0 / 100
Reference Date: 2026-07-24
Company InformationBased on 2025 Annual Report
Business Overview
CMG Pharmaceutical is a core subsidiary of Chabiotech Group, specializing in the R&D, production, and sales of pharmaceuticals and health functional foods. The company focuses on developing improved new drugs using its proprietary STARFILM Technology, which enables unique taste and stability in oral disintegrating films (ODF). It is expanding into high-growth sectors such as oncology, anti-aging, ophthalmology, and maternal and baby care, while also operating an animal pharmaceutical business through its subsidiaries to enhance shareholder value.
Number of Employees
206people
Average Salary
62.8M KRW
Score Calculation Basis
Detailed Financial Score
Lower than industry avg (good)
Well below industry avg
Half of industry avg (excellent)
Avg ▲5.9% (2-year basis)
Avg ▼264.1% (2-year basis)
Avg ROE -0.1% (declining, 3yr)
Detailed News Sentiment
- Neutral튜브 대신 립밤, 알약 대신 필름…제약업계 '편의성 전쟁'
제약업계의 편의성 향상 전략이 언급되었으나, 특정 종목인 CMG제약에 직접적인 영향은 명시되지 않았습니다.
Detailed Momentum
Near 52w low (0%, downtrend)
1m -14.61% (falling)
Volume decreasing
Detailed Disclosure
- Neutral주주명부폐쇄기간또는기준일설정2026-07-22
- Neutral주식병합결정2026-07-22
- Neutral주주총회소집결의 (임시주주총회)2026-07-22
- Neutral전환사채(해외전환사채포함)발행후만기전사채취득2026-07-13
- Neutral주식등의대량보유상황보고서(약식)2026-07-07
